healthcare · Federal Select Agent Program · NIH Guidelines · DURC Policy
Synthetic Biology / Biosecurity
Screening AI failure = criminal liability under Select Agent regulations
—Federal Select Agent Program + DURC
Regulatory exposure — commonly overlooked:
Cloud lab orders sequence — lab owns biosecurity violation, screening vendor owns API uptime SLA. · Multinationals built for one jurisdiction fail exams in another — one receipt architecture, many filing packs.
TAM / Exposure
Synthetic biology market $80B+ · DNA synthesis screening mandatory
Insurance lines
Biotech E&O · Product liability
Exhibit authority
Global External Validation — Biosecurity AI Screening Pack
Global leaders
CDC · Ginkgo Bioworks · Twist Bioscience · NIH · WHO · ISO · NIST · OECD
DURC policy
Dual use research of concern — AI screening decision must be documented for IBC review.
Sequence orders
Every synthesis order needs screening receipt — HHS 2010 framework now AI-accelerated.
Insurance exclusion
Biotech policies excluding unscreened AI sequence design.